tuftsin has been researched along with rifampin in 3 studies
| Studies (tuftsin) | Trials (tuftsin) | Recent Studies (post-2010) (tuftsin) | Studies (rifampin) | Trials (rifampin) | Recent Studies (post-2010) (rifampin) |
|---|---|---|---|---|---|
| 534 | 4 | 58 | 20,468 | 1,499 | 6,552 |
| Protein | Taxonomy | tuftsin (IC50) | rifampin (IC50) |
|---|---|---|---|
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.949 | |
| Caspase-1 | Homo sapiens (human) | 8.319 | |
| Alpha-synuclein | Homo sapiens (human) | 7.1 | |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 0.03 | |
| DNA-directed RNA polymerase subunit beta | Mycobacterium tuberculosis H37Rv | 0.01 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.5 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anokhina, VV; Eskina, IM; Freĭdlin, IS; Iushchenko, AA; Iushin, MIu; Urliapova, NG; Vishnevetskiĭ, FE; Vishnevetskiĭ, RF | 1 |
| Agarwal, A; Gupta, CM; Gupta, HP; Kandpal, H; Singh, NB | 1 |
| Carneiro, CM; Carneiro, SP; Carvalho, KV; de Andrade, MHG; de Oliveira Aguiar Soares, RD; Dos Santos, ODH; Duarte, RS | 1 |
3 other study(ies) available for tuftsin and rifampin
| Article | Year |
|---|---|
[Use of tuftsin in experimental leprosy].
Topics: Animals; Cell Line; Dapsone; Leprosy; Mice; Mice, Inbred CBA; Mycobacterium leprae; Rifampin; Tuftsin | 1991 |
Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice.
Topics: Amino Acid Sequence; Animals; Colony Count, Microbial; Drug Carriers; Liposomes; Lung; Macrophages; Mice; Molecular Sequence Data; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary; Tuftsin | 1994 |
Functionalized rifampicin-loaded nanostructured lipid carriers enhance macrophages uptake and antimycobacterial activity.
Topics: Animals; Antitubercular Agents; Cell Line; Cell Survival; Drug Carriers; Drug Liberation; Lipids; Macrophages; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nanostructures; Rifampin; Tuftsin | 2019 |